SEC Form 4 · accession 0001209191-17-063221
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M. Andrew Wade
Officer — SVP and CFO
Period of report
Nov 30, 2017
Accepted (ET)
Dec 1, 2017 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2017 | M | 2,000 | $11.65 | A | 163,950 | D | |
| Common StockF1 | Nov 30, 2017 | S | 2,000 | $18.41 | D | 161,950 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $11.65 | Nov 30, 2017 | M | 2,000 | D | Dec 5, 2008 | Dec 5, 2017 | Common Stock | 2,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $18.40 to $18.50 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This option was granted on December 5, 2007 and is exercisable as to 25% of the shares upon the one year anniversary of the date of the grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.